In my role as a product leader, it’s always important to stay on top of trends and changes in the …
Intelligent Engineering for Clinical Trial Management
Engility CTMS has been designed and developed utilising agile engineering practices with extensive automation to ensure that validation assets can be generated with higher accuracy and quality utilising the PHARMASEAL continuous validation framework.
Our automated continuous validation framework reduces the time it takes to validate the system. Whilst validation is required in a regulated industry, our approach allows us to increase the pace of innovation in a controlled way. Innovative CTMS systems that are engineered for change offer extensive automation to deliver new features in a regulated industry, faster than current products. Intuitive systems that utilize flexible cloud architecture allow biopharmaceutical and medical device companies of all sizes to leverage affordable enterprise technology to fit their individual organisation model, expediating clinical development.
PHARMASEAL was founded in 2016 by a team of industry leaders who share a vision to create smarter technologies and innovative products for the improvement of human health.
The company’s first product Engility CTMS simplifies the management and control of clinical trials for biopharmaceutical and medical device companies. Engility CTMS utilises advanced engineering offering enterprise management with rapid deployment, an intuitive user interface and interoperability with other eClinical applications to optimise trial governance and oversight.
Why Clinical Research?
“Why” is a common question asked by runners, generally asked to themselves or asked by non-runners. …
PHARMASEAL Launches Second Major Release of Engility™ CTMS
PHARMASEAL, a new provider of clinical trial management and governance solutions to enter the …